header-logo header-logo

03 December 2009 / Richard Scorer
Issue: 7396 / Categories: Features , Personal injury
printer mail-detail

Silent killer

Pleural plaques—where now? asks Richard Scorer

Asbestos, which was used extensively in industry in the 19th and 20th centuries, is made up of microscopic fibres which can be inhaled into a person’s lung. Such fibres can cause lung disease, which can often be fatal or seriously disabling.

Asbestos disease often has a long latency period, sometimes as long as 50 years. This means that the number of victims is continuing to rise even though the actual use of asbestos in industry has drastically declined.

There are several common types of asbestos related conditions. Pleural plaques are one such condition and have figured prominently in personal injury litigation. Pleural plaques are a type of scarring on the lung. They can sometimes be a precursor to fatal asbestos related illnesses, for example mesothelioma. However, pleural plaques are distinctive from other types of asbestos related conditions because in most cases they are symptom free.

The person afflicted by pleural plaques will not experience any physical pain or suffering and in many cases will never become ill at all. However, the person afflicted may become very anxious about the

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Jurit LLP—Caroline Williams

Jurit LLP—Caroline Williams

Private wealth and tax team welcomes cross-border specialist as consultant

Freeths—Michelle Kirkland Elias

Freeths—Michelle Kirkland Elias

International hospitality and leisure specialist joins corporate team as partner

Flint Bishop—Deborah Niven

Flint Bishop—Deborah Niven

Firm appoints head of intellectual property to drive northern growth

NEWS
Talk of a reserved ‘Welsh seat’ on the Supreme Court is misplaced. In NLJ this week, Professor Graham Zellick KC explains that the Constitutional Reform Act treats ‘England and Wales’ as one jurisdiction, with no statutory Welsh slot
The government’s plan to curb jury trials has sparked ‘jury furore’. Writing in NLJ this week, David Locke, partner at Hill Dickinson, says the rationale is ‘grossly inadequate’
A year after the $1.5bn Bybit heist, crypto fraud is booming—but so is recovery. Writing in NLJ this week, Neil Holloway, founder and CEO of M2 Recovery, warns that scams hit at least $14bn in 2025, fuelled by ‘pig butchering’ cons and AI deepfakes
After Woodcock confirmed no general duty to warn, debate turns to the criminal law. Writing in NLJ this week, Charles Davey of The Barrister Group urges revival of misprision or a modern equivalent
Family courts are tightening control of expert evidence. Writing in NLJ this week, Dr Chris Pamplin says there is ‘no automatic right’ to call experts; attendance must be ‘necessary in the interests of justice’ under FPR Pt 25
back-to-top-scroll